Controversies in the treatment of idiopathic membranous nephropathy.
about
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndromeCirculating TNF receptors are significant prognostic biomarkers for idiopathic membranous nephropathyMurine membranous nephropathy: immunization with α3(IV) collagen fragment induces subepithelial immune complexes and FcγR-independent nephrotic syndrome.Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers.Antioxidants in kidney diseases: the impact of bardoxolone methyl.A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study.Treatment pattern in patients with idiopathic membranous nephropathy-practices in Sweden at the start of the millenniumImmunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trialsProteomics in chronic kidney disease: The issues clinical nephrologists need an answer for.Pathogenesis of membranous nephropathy: recent advances and future challenges.Diagnostic value of phospholipase A2 receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis.Immunopathogenesis of membranous nephropathy: an update.Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.Out of Africa: Complete and partial remissions as a combined outcome in patients with idiopathic membranous glomerulonephritis in Cape Town.A novel Time-resolved Fluoroimmunoassay for the quantitative detection of Antibodies against the Phospholipase A2 Receptor.Mouse models of membranous nephropathy: the road less travelled by.Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.[Pathophysiology of extramembranous glomerulopathies. Fifty years of progress, from laboratory to patient].Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy.
P2860
Q24193098-43D9F9CD-FBAF-4568-AE28-967E740FA059Q34011274-836717AA-A550-43FB-8591-8B686A1FC499Q35851046-853BFCF5-FFDD-486F-8DC0-9683E52515A8Q35862682-B7853E84-8F72-41DE-8C39-F1CF920248EDQ36026304-44861055-5BE4-40F1-9539-CCFE3D64E85BQ36088887-BA84ED33-BDCA-4A01-BB08-A889A4607B96Q36689205-BB3CED29-AC65-4388-8509-66FFC073D56DQ36810470-F35C59F4-BBB6-4EB2-ADE0-2B06E0B3F943Q37871572-96C59926-6626-4AF4-B47B-A5BCA3B4A46EQ37988806-6BB63E04-12C7-4AE6-9E09-BBF635D638DCQ38185614-6AAEABBC-45BA-4678-9C4D-9DB293180996Q38203172-731BE362-A892-4653-8BCE-986962F0F518Q38399066-4314BCBE-38A8-47E2-85C6-6A0698D40A70Q38680011-E4843C04-4C6F-4BD9-AC58-465C96AEA661Q42292300-CD7F92DE-7471-461D-9D93-51AB16A3B5A9Q43087986-8FC6DACA-EF7B-49C8-BD52-13877D9EFA9EQ44420378-C0E679FB-399E-4D5B-BDAF-A26951D61FAFQ46208311-294D05E1-05E7-4674-9457-C8B83467F4F3Q47888913-E92E69F1-637B-4740-9A1F-F032FDF764AA
P2860
Controversies in the treatment of idiopathic membranous nephropathy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Controversies in the treatment of idiopathic membranous nephropathy.
@ast
Controversies in the treatment of idiopathic membranous nephropathy.
@en
Controversies in the treatment of idiopathic membranous nephropathy.
@nl
type
label
Controversies in the treatment of idiopathic membranous nephropathy.
@ast
Controversies in the treatment of idiopathic membranous nephropathy.
@en
Controversies in the treatment of idiopathic membranous nephropathy.
@nl
prefLabel
Controversies in the treatment of idiopathic membranous nephropathy.
@ast
Controversies in the treatment of idiopathic membranous nephropathy.
@en
Controversies in the treatment of idiopathic membranous nephropathy.
@nl
P2860
P356
P1476
Controversies in the treatment of idiopathic membranous nephropathy.
@en
P2093
Howard A Austin
Meryl Waldman
P2860
P2888
P304
P356
10.1038/NRNEPH.2009.101
P407
P577
2009-07-07T00:00:00Z